The following table shows estimated expenditure on epilepsy research and development by the National Institute for Health (NIHR) through its research programmes, research centres and units and research fellowships.<\/p>
<\/p>
<\/p>
<\/p>
£ million<\/em><\/p> <\/p> <\/p><\/td> 2009/10<\/p><\/td> 2010/11<\/p><\/td> 2011/12<\/p><\/td> 2012/13<\/p><\/td> 2013/14<\/p><\/td><\/tr> National Institute for Health Research<\/p><\/td> 0.8<\/p><\/td> 1.0<\/p><\/td> 1.3<\/p><\/td> 2.7<\/p><\/td> 3.1<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> Total spend by the NIHR on epilepsy is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on this condition cannot be disaggregated from total CRN expenditure.<\/p> <\/p> <\/p> <\/p> The following table shows estimated expenditure on research on epilepsy by the Research Councils and Innovate UK.<\/p> <\/p> <\/p> <\/p> £ million<\/em><\/p> <\/p> <\/p><\/td> 2009/10<\/p><\/td> 2010/11<\/p><\/td> 2011/12<\/p><\/td> 2012/13<\/p><\/td> 2013/14<\/p><\/td><\/tr> Research Councils and Innovate UK<\/p><\/td> 4.2<\/p><\/td> 3.5<\/p><\/td> 2.0<\/p><\/td> 2.3<\/p><\/td> 3.1<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> In addition to research directly relating to epilepsy, the Medical Research Council also supports a broad portfolio of research that aims to improve our understanding of the underlying mechanisms of neuroscience and neurological conditions including epilepsy.<\/p> <\/p> <\/p> <\/p> The following table shows estimated expenditure on development of new drugs and treatments for epilepsy by the Research Councils and Innovate UK.<\/p> <\/p> <\/p> <\/p> £ million<\/em><\/p> <\/p> <\/p><\/td> 2009/10<\/p><\/td> 2010/11<\/p><\/td> 2011/12<\/p><\/td> 2012/13<\/p><\/td> 2013/14<\/p><\/td><\/tr> Research Councils and Innovate UK<\/p><\/td> 0.1<\/p><\/td> 0.2<\/p><\/td> 0.3<\/p><\/td> 0.3<\/p><\/td> 0.4<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2015-03-04", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "225699"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-04T17:25:17.93Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-02-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Epilepsy"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much public money has been invested into development of new drugs and treatments for epilepsy in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester West"}
, "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
], "uin" : "225706"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}